Darden FY27 Q1: sales up 5.1% to $3.20 billion, EPS $2.05, outlook held
Darden opened fiscal 2027 with sales up 5.1% to $3.20 billion and $2.05 of diluted EPS from continuing operations, yet reported net income fell 9.5% to $233.4 million because last year's quarter carried a $42.0 million gain on the Olive Garden Canada sale. Strip that out and earnings per share rose 4.1%. Read the segment table before the headline EPS number.
1 · Expected vs. Actual
Free preview belowDiluted EPS from continuing operations was $2.05 versus $2.19 a year ago, but that comparison is distorted by the prior-year Canada gain; against last year's adjusted $1.97, EPS rose 4.1%. A 2.7% smaller diluted share count of 114.4 million did part of that work. On a reported basis net income of $233.4 million was down 9.5% and operating margin slipped to 10.0% from 11.1%.
Sales rose 5.1% to $3.20 billion from $3.04 billion, and every segment delivered positive same-restaurant sales. LongHorn did the heavy lifting, with sales up 10.9% to $860.9 million and same-restaurant sales up 6.2%. Olive Garden, at $1.33 billion, grew sales only 2.2% on same-restaurant sales of 1.1%.
Log in to read 35 analyses a week for free
Create a free account to read 35 full earnings analyses each week — all five steps: expected vs. actual, guidance tracker, money flow, balance sheet and risks. Members get unlimited access.
Figures on this page come from the company's original SEC filings. The analysis is generated automatically and checked against validation rules, but may still contain errors or omissions. Not investment advice. · Generated 2026-11-03
Answers are based on the earnings release and the analysis above. Free accounts get 3 questions a week; members get 30 a day.